Abiopharma

H.B. Fuller Reports Second Quarter 2025 Results

Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies

New Form 4 - Cencora, Inc. Filed: 2025-06-25 AccNo: 0001140859-25-000111 Size: 8 KB

New Form 144 - Doximity, Inc. Filed: 2025-06-25 AccNo: 0001950047-25-004599 Size: 4 KB

New Form 8-K - Phreesia, Inc. Filed: 2025-06-25 AccNo: 0001412408-25-000047 Size: 150 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 144 - Immunovant, Inc. Filed: 2025-06-25 AccNo: 0001950047-25-004598 Size: 8 KB

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

New Form 8-K - FEMASYS INC Filed: 2025-06-25 AccNo: 0001140361-25-023642 Size: 170 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - Theriva Biologics, Inc. Filed: 2025-06-25 AccNo: 0001104659-25-062559 Size: 192 KB Item 8.01: Other Events

New Form SCHEDULE 13G - ARDELYX, INC. Filed: 2025-06-25 AccNo: 0001104659-25-062560 Size: 18 KB

New Form S-8 - MOLECULAR PARTNERS AG Filed: 2025-06-25 AccNo: 0001745114-25-000026 Size: 469 KB

Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

New Form 4 - Nkarta, Inc. Filed: 2025-06-25 AccNo: 0000950170-25-089939 Size: 5 KB

New Form 3 - Nkarta, Inc. Filed: 2025-06-25 AccNo: 0000950170-25-089938 Size: 23 KB